🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label study of MABp1 in six healthy volunteers. Participant...
Status
Completed
Location
XBiotech Investigative Site
Start Date
2017-02-15
Trial ID
NCT03047317
Treatments Being Tested
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder. Alth...
Status
Completed
Location
4th Department of Internal Medicine, ATTIKON University Hospital
Start Date
2015-12
Trial ID
NCT02643654
Phase 2 study of bermekimab in patients with moderate to severe Hidradeniti...
Status
Completed
Location
Tennessee Clinical Research Center
Start Date
2018-06-20
Trial ID
NCT03512275
Treatments Being Tested
This is a proof-of concept RCT trying to generate evidence that inhibition ...
Status
Completed
Location
Department of Pathophysiology, LAIKO Athens General Hospital
Start Date
2019-07-19
Trial ID
NCT04045743
Treatments Being Tested
A Phase 2 study of Bermekimab (MABp1) in patients with atopic dermatitis....
Status
Completed
Location
Florida Academic Centers Research & Education
Start Date
2018-05-21
Trial ID
NCT03496974
Treatments Being Tested
The purpose of this study is to determine if the True Human Monoclonal anti...
Status
Terminated
Location
Alabama Oncology, Bruno Cancer Center
Start Date
2013-03-31
Trial ID
NCT01767857
The purpose of this study is to block interleukin-1 alpha activity with a T...
Status
Completed
Location
M.D. Anderson Cancer Institute
Start Date
2010-03-31
Trial ID
NCT01021072
Treatments Being Tested
The purpose of this study is to determine if T2-18C3, a true human monoclon...
Status
Completed
Location
University Hospital of Basel
Start Date
2011-06-30
Trial ID
NCT01427699
Treatments Being Tested